Willingness to initiate insulin among adults with type 2 diabetes in Australian primary care: Results from the Stepping Up Study

Diabetes Research and Clinical Practice

Volumn 114, Issue , 2016, Pages 126-135

  Holmes Truscott, Elizabeth ^a,b   Blackberry, Irene ^c,d   O'Neal, David N ^c   Furler, John S ^c   Speight, Jane ^a,b,e  

^a THE AUSTRALIAN CENTRE FOR BEHAVIOURAL RESEARCH IN DIABETES   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e AHP Research   (United Kingdom)

Author keywords

Insulin therapy; Primary care; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

ADULT; ARTICLE; AUSTRALIA; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISTRESS SYNDROME; DRUG INDICATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PREDICTION; PRIMARY MEDICAL CARE; PSYCHOLOGICAL WELL BEING; RANDOMIZED CONTROLLED TRIAL; SOCIAL STATUS; CROSS-SECTIONAL STUDY; DECISION MAKING; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; PSYCHOLOGY;

ADULT; AUSTRALIA; CROSS-SECTIONAL STUDIES; DECISION MAKING; DEPRESSION; DIABETES MELLITUS, TYPE 2; DRUG THERAPY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE;

EID: 84955105714     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.12.011     Document Type: Article

References (49)

1. Holman R.R. Assessing the potential for α-glucosidase inhibitors in prediabetic states. Diabetes Res Clin Pract 1998, 40:S21-S25.
2. Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009, 52(1):17-30.
3. UKPDS Overview of 6 years' therapy of type II diabetes: a progressive disease (UKPDS 16). Diabetes 1995, 44(11):1249-1258.
4. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131):837-853.
5. Khunti K., Wolden M.L., Thorsted B.L., Andersen M., Davies M.J. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care 2013, 36(11):3411-3417.
6. Zafar A., Davies M., Azhar A., Khunti K. Clinical inertia in management of T2DM. Prim Care Diabetes 2010, 4(4):203-207.
7. Leslie C.A., Satin-Rapaport W. Psychological insulin resistance-a challenge for diabetes patients and health professionals. Today's Ther Trends 1995, 13(1):21-27.
8. Polonsky W.H., Jackson R.A. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes 2004, 22(3):147-150.
9. Leslie C.A., Satin-Rapaport W., Matheson D., Stone R., Enfield G. Psychological insulin resistance: a missed diagnosis. Diabetes Spectr 1994, 7(1):52-57.
10. UKPDS Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years (UKPDS 13). BMJ 1995, 310(6972):83-88.
11. Khan H., Lasker S.S., Chowdhury T.A. Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled type 2 diabetes in East London. Diabet Med 2008, 25(9):1108-1111.
12. Polonsky W.H., Fisher L., Dowe S., Edelman S.V. Why do patients resist insulin therapy?. Diabetes 2003, 52(Suppl. 1):A417. [Abstract].
13. Machinani S., Bazargan-Hejazi S., Hsia S.H. Psychological insulin resistance among low-income, US racial minority patients with type 2 diabetes. Prim Care Diabetes 2013, 7(1):51-55.
14. Larkin M.E., Capasso V.A., Chen C.L., Mahoney E.K., Hazard B., Cagliero E., et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ 2008, 34(3):511-517.
15. Wong S., Lee J., Ko Y., Chong M.F., Lam C.K., Tang W.E. Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore. Diabet Med 2011, 28(2):206-211.
16. Polonsky W.H., Fisher L., Guzman S., Villa-Caballero L., Edelman S.V. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005, 28(10):2543-2545.
17. Nur Azmiah Z., Zulkarnain A.K., Tahir A. Psychological insulin resistance (PIR) among type 2 diabetes patients at public health clinics in federal territory of Malaysia. Int Med J Malays 2011, 10(2):7-12.
18. Polonsky W.H., Hajos T.R.S., Dain M.P., Snoek F.J. Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population. Curr Med Res Opin 2011, 27(6):1169-1174.
19. Woudenberg Y.J.C., Lucas C., Latour C., Scholte op Reimer W.J.M. Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary care. Diabet Med 2012, 29(6):796-802.
20. Gherman A., Veresiu I.A., Sassu R.A., Schnur J.B., Scheckner B.L., Montgomery G.H. Psychological insulin resistance: a critical review of the literature. Pract Diabetes Int 2011, 28(3):125-8d.
21. Wang H.F., Yeh M.C. Psychological resistance to insulin therapy in adults with type 2 diabetes: mixed-method systematic review. J Adv Nurs 2012, 68(4):743-757.
22. Conner M., Norman P. Predicting health behaviour 1996, Open University Press, Buckingham.
23. Holmes-Truscott E., Skinner T., Pouwer F., Speight J. Explaining psychological insulin resistance in adults with non-insulin-treated type 2 diabetes: the roles of diabetes distress and current medication concerns. Results from Diabetes MILES-Australia. Prim Care Diabetes 2016, 10(1):75-82.
24. Makine C., Karşida Ç., Kadio lu P., Ilkova H., Karşida K., Skovlund S.E., et al. Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naïve patients with Type 2 diabetes mellitus. a study from the European Depression in Diabetes [EDID] Research Consortium. Diabet Med 2009, 26(1):28-33.
25. Furler J., Young D., Best J., Patterson E., O'Neal D., Liew D., et al. Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol. Implement Sci 2014, 9(1):20.
26. Snoek F.J., Skovlund S.E., Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes 2007, 5:69.
27. Holmes-Truscott E., Pouwer F., Speight J. Further investigation of the psychometric properties of the insulin treatment appraisal scale among insulin-using and non-insulin-using adults with type 2 diabetes: results from diabetes MILES-Australia. Health Qual Life Outcomes 2014, 12(1):87.
28. Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16(9):606-613.
29. Polonsky W.H., Anderson B.J., Lohrer P.A., Welch G., Jacobson A.M., Aponte J.E., et al. Assessment of diabetes-related distress. Diabetes Care 1995, 18(6):754-760.
30. Snoek F.J., Kersch N.Y.A., Eldrup E., Harman-Boehm I., Hermanns N., Kokoszka A., et al. Monitoring of individual needs in diabetes (MIND): baseline data from the cross-national diabetes attitudes. Wishes, and needs (DAWN) MIND study. Diabetes Care 2011, 34(3):601-603.
31. Horne R., Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999, 47(6):555-567.
32. Australian Bureau of Statistics Socio-economic indexes for areas 2011 2011, Available from: 〈http://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa〉 [cited 2014, 14 September].
33. Barnett K., Mercer S.W., Norbury M., Watt G., Wyke S., Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet 2012, 380(9836):37-43.
34. Jenkins N., Hallowell N., Farmer A.J., Holman R.R., Lawton J. Initiating insulin as part of the treating to target in type 2 diabetes (4-T) trial: an interview study of patients' and health professionals' experiences. Diabetes Care 2010, 33(10):2178-2180.
35. Jenkins N., Hallowell N., Farmer A.J., Holman R.R., Lawton J. Participants' experiences of intensifying insulin therapy during the treating to target in type 2 diabetes (4-T) trial: qualitative interview study. Diabet Med 2011, 28(5):543-548.
36. Speight J., Browne J.L., Holmes-Truscott E., Hendrieckx C., Pouwer F. On Behalf of Diabetes MILES-Australia Reference Group. Diabetes MILES-Australia 2011 survey report 2011, Diabetes Australia, Canberra.
37. Holmes-Truscott E., Skinner T.C., Pouwer F., Speight J. Negative appraisals of insulin therapy are common among adults with Type 2 diabetes using insulin: results from Diabetes MILES-Australia cross-sectional survey. Diabet Med 2015, 32(10):1297-1303.
38. Nefs G., Pop V.J.M., Denollet J., Pouwer F. The longitudinal association between depressive symptoms and initiation of insulin therapy in people with type 2 diabetes in primary care. PLoS ONE 2013, 8(11):e78865.
39. Lee P.Y., Lee Y.K., Ng C.J. How can insulin initiation delivery in a dual-sector health system be optimised? A qualitative study on healthcare professionals' views. BMC Public Health 2012, 12(1):313.
40. Jeavons D., Hungin A.P.S., Cornford C.S. Patients with poorly controlled diabetes in primary care: healthcare clinicians' beliefs and attitudes. Postgrad Med J 2006, 82(967):347-350.
41. Phillips A. Starting patients on insulin therapy: diabetes nurse specialist views. Nurs Stand 2007, 21(30):35-40.
42. Patel N., Stone M.A., Chauhan A., Davies M.J., Khunti K. Insulin initiation and management in people with Type 2 diabetes in an ethnically diverse population: the healthcare provider perspective. Diabet Med 2012, 29(10):1311-1316.
43. Shah B.R., Hux J.E., Laupacis A., Zinman B., van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?. Diabetes Care 2005, 28(3):600-606.
44. Furler J., Spitzer O., Young D., Best J. Insulin in general practice: barriers and enablers for timely initiation. Aust Fam Physician 2011, 40(8):617-621.
45. Meneghini L., Artola S., Caputo S., Damci T., Dzida G., Kaiser M., et al. Practical guidance to insulin management. Prim Care Diabetes 2010, 4:S43-S56.
46. Speight J., Conn J., Dunning T., Skinner T. Diabetes Australia position statement. A new language for diabetes: improving communications with and about people with diabetes. Diabetes Res Clin Pract 2012, 97(3):425-431.
47. Polonsky W.H. Psychological insulin resistance: the patient perspective. Diabetes Educ 2007, 33(Suppl. 7):241S-244S.
48. Clark M. Psychological insulin resistance: a guide for practice nurses. J Diabetes Nurs 2007, 11(2):53-56.
49. Reid T.S. Insulin for type 2 diabetes mellitus: separating the myths from the facts. Insulin 2007, 2(4):182-189.